ð¥ ä»é±ã¯3ã€ã®PDUFAå€æããããŸãïŒ ð
ð ä»é±ã®PDUFAsïŒ
$ã¡ã«ã¯ (MRK.US)$ : ð€
âš Patritumab deruxtecan
⣠éå°çŽ°èèºç
⣠PDUFAæ¥ä»ïŒ6/26/24 (BLA)
ðïžå
é±ã®PDUFAs:
$ã¡ã«ã¯ (MRK.US)$ïŒæ¿èªæžã¿6/17 ð
âšCAPVAXIVEïŒV116ïŒ
ã»èºççèçµåã¯ã¯ãã³
ã»PDUFAæ¥ïŒ6/17/24ïŒBLAïŒ
$ã¡ã«ã¯ (MRK.US)$ïŒæ¿èªæžã¿6/17 ð
âšKEYTRUDA + ã«ã«ããã©ãã³+ ãã¯ãªã¿ãã»ã«
ã»åå®®å
èç
PDUFAæ¥ïŒ6/21/24ïŒsBLAïŒ
$ã¢ã«ãžã§ã³X (ARGX.US)$æ¿èªæžã¿6/21 ð
âšVYVGART HytruloïŒãšãã¬ã«ããŽã¢ãïŒ
ã»æ
¢æ§ççæ§è±é«æ§å€çºç¥çµçïŒCIDPïŒ
PDUFAæ¥ïŒ6/21/24ïŒsBLAïŒ